IS7723A - Efnasambönd sem eru gagnleg til meðhöndlunar á sjúkdómum sem svara meðferð sem bælir æðamyndun - Google Patents

Efnasambönd sem eru gagnleg til meðhöndlunar á sjúkdómum sem svara meðferð sem bælir æðamyndun

Info

Publication number
IS7723A
IS7723A IS7723A IS7723A IS7723A IS 7723 A IS7723 A IS 7723A IS 7723 A IS7723 A IS 7723A IS 7723 A IS7723 A IS 7723A IS 7723 A IS7723 A IS 7723A
Authority
IS
Iceland
Prior art keywords
treatment
compounds
angiogenic
useful
diseases
Prior art date
Application number
IS7723A
Other languages
English (en)
Inventor
Lichtenberg Jens
Christophersen Palle
H. Dahl Bjarne
Original Assignee
Neurosearch A/S
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neurosearch A/S filed Critical Neurosearch A/S
Publication of IS7723A publication Critical patent/IS7723A/is

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Ophthalmology & Optometry (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Pain & Pain Management (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Electrotherapy Devices (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Inorganic Compounds Of Heavy Metals (AREA)
  • Plural Heterocyclic Compounds (AREA)
IS7723A 2002-08-01 2005-03-01 Efnasambönd sem eru gagnleg til meðhöndlunar á sjúkdómum sem svara meðferð sem bælir æðamyndun IS7723A (is)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DKPA200201165 2002-08-01
DKPA200201839 2002-11-28
DKPA200300371 2003-03-11
PCT/DK2003/000518 WO2004012733A2 (en) 2002-08-01 2003-07-31 Compounds useful for the treatment of diseases responsive to antiangiogenetic therapy

Publications (1)

Publication Number Publication Date
IS7723A true IS7723A (is) 2005-03-01

Family

ID=31498946

Family Applications (1)

Application Number Title Priority Date Filing Date
IS7723A IS7723A (is) 2002-08-01 2005-03-01 Efnasambönd sem eru gagnleg til meðhöndlunar á sjúkdómum sem svara meðferð sem bælir æðamyndun

Country Status (17)

Country Link
US (1) US20060058395A1 (is)
EP (1) EP1526851B1 (is)
JP (1) JP2005537336A (is)
KR (1) KR20050026091A (is)
CN (1) CN1671378A (is)
AT (1) ATE372770T1 (is)
AU (1) AU2003260280A1 (is)
BR (1) BR0312929A (is)
CA (1) CA2493253A1 (is)
DE (1) DE60316297T2 (is)
IL (1) IL166040A0 (is)
IS (1) IS7723A (is)
MX (1) MXPA05001235A (is)
NO (1) NO20051074L (is)
NZ (1) NZ537809A (is)
PL (1) PL375318A1 (is)
WO (1) WO2004012733A2 (is)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE411301T1 (de) * 2003-06-17 2008-10-15 Neurosearch As Diphenylurea-derivative und ihre verwendung als chloridkanalblocker
US7550499B2 (en) 2004-05-12 2009-06-23 Bristol-Myers Squibb Company Urea antagonists of P2Y1 receptor useful in the treatment of thrombotic conditions
WO2006078621A2 (en) 2005-01-19 2006-07-27 Bristol-Myers Squibb Company 2-phenoxy-n- (1, 3 , 4-thiadizol-2-yl) pyridin-3-amine derivatives and related compounds as p2y1 receptor inhibitors for the treatment of thromboembolic disorders
EP1853286A2 (en) * 2005-02-08 2007-11-14 BMZ Diagnosis (2004) Ltd. Composition for treatment of skin disorders
DE602006017694D1 (de) 2005-06-27 2010-12-02 Bristol Myers Squibb Co C-verknüpfte zyklische antagonisten des p2y1-rezeptors mit eignung bei der behandlung thrombotischer leiden
ATE502924T1 (de) 2005-06-27 2011-04-15 Bristol Myers Squibb Co Lineare harnstoffmimetika-antagonisten des p2y1- rezeptors zur behandlung von thromboseleiden
WO2007002634A1 (en) 2005-06-27 2007-01-04 Bristol-Myers Squibb Company Carbocycle and heterocycle antagonists of p2y1 receptor useful in the treatment of thrombotic conditions
TW200726764A (en) 2005-06-27 2007-07-16 Bristol Myers Squibb Co N-linked heterocyclic antagonists of P2Y1 receptor useful in the treatment of thrombotic conditions
US7960569B2 (en) 2006-10-17 2011-06-14 Bristol-Myers Squibb Company Indole antagonists of P2Y1 receptor useful in the treatment of thrombotic conditions
US20110110958A1 (en) * 2007-09-11 2011-05-12 University Of Florida Research Foundation Compositions and methods for the treatment of neoplasia
WO2016001452A1 (en) * 2014-07-04 2016-01-07 Universität Zürich Compounds, in particular for use in the treatment of a disease or condition for which a bromodomain inhibitor is indicated
EP3458052B1 (en) * 2016-05-17 2019-11-06 Scandion Oncology A/S Combination treatment of cancer
US20210251963A1 (en) * 2018-09-06 2021-08-19 Scandion Oncology A/S Urea derivatives for use in the treatment of subjects with elevated expression and/or activity of srpk1

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH11503110A (ja) * 1995-02-17 1999-03-23 スミスクライン・ビーチャム・コーポレイション Ｉｌ−８受容体拮抗剤
US6297261B1 (en) * 1997-04-22 2001-10-02 Neurosearch A/S Substituted phenyl derivatives, their preparation and use
CN1213022C (zh) * 1997-12-22 2005-08-03 拜尔有限公司 用对称和不对称的取代二苯脲抑制raf激酶
PL198852B1 (pl) * 1998-10-22 2008-07-31 Neurosearch As Podstawione pochodne fenylu, kompozycja farmaceutyczna je zawierająca oraz ich zastosowanie
CO5200760A1 (es) * 1999-06-16 2002-09-27 Smithkline Beecham Corp Antagonistas del receptor de la il-8 ceptor il-8
BR0312503A (pt) * 2002-07-09 2007-06-26 Bristol Myers Squibb Co derivados heterocìclicos substituìdos úteis como agentes antidiabéticos e antiobesidade, composição farmacêutica, uso e combinação dos mesmos

Also Published As

Publication number Publication date
DE60316297T2 (de) 2008-06-19
EP1526851B1 (en) 2007-09-12
WO2004012733A3 (en) 2004-03-18
CA2493253A1 (en) 2004-02-12
NO20051074L (no) 2005-04-29
BR0312929A (pt) 2005-07-12
PL375318A1 (en) 2005-11-28
WO2004012733A9 (en) 2005-03-10
ATE372770T1 (de) 2007-09-15
NZ537809A (en) 2007-05-31
DE60316297D1 (de) 2007-10-25
WO2004012733A2 (en) 2004-02-12
KR20050026091A (ko) 2005-03-14
US20060058395A1 (en) 2006-03-16
CN1671378A (zh) 2005-09-21
MXPA05001235A (es) 2005-06-08
EP1526851A2 (en) 2005-05-04
IL166040A0 (en) 2006-01-15
AU2003260280A1 (en) 2004-02-23
JP2005537336A (ja) 2005-12-08

Similar Documents

Publication Publication Date Title
AU2003272285A8 (en) Thienopyrrolyl and furanopyrrolyl compounds and their use as histamine h4 receptor ligands
IS7723A (is) Efnasambönd sem eru gagnleg til meðhöndlunar á sjúkdómum sem svara meðferð sem bælir æðamyndun
TW200509892A (en) Novel aminobenzophenone compounds
MY145077A (en) Pyrrolotriazine derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis
GEP20084520B (en) Use of retinyl derivatives and compositions thereof for treating ophthalmic diseases
EA200801372A1 (ru) Способы получения замещенных пиримидинов
UA83194C2 (ru) Производные пиримидина и их применение как модуляторов св2
MXPA03005696A (es) Pirimidinaminas como moduladores de angiogenesis.
WO2004108139A3 (en) Use of fused heterocyclic compounds as scce inhibitors for the treatment of skin conditions or cancer
AU2003220970A1 (en) Diamino-pyrimidines and their use as angiogenesis inhibitors
GB0222495D0 (en) Compounds
IL172942A0 (en) Pyrazoloisoquinoline derivatives as kinase inhibitors
TW200631583A (en) Substituted pteridines for the treatment of inflammatory diseases
TWI319708B (en) Methods and compositions for altering cell fuction
MY141528A (en) Anilinopyrazole derivatives useful for the treatment of diabetes
DE602006016449D1 (is)
NO20054371L (no) Somatostatin-dopamin kimaere analoger
BR0312446A (pt) 2-heteroaril carboxamidas
MY149492A (en) Immunoglobulins directed against nogo
WO2004043379A3 (en) Chemical compounds
WO2004069160A3 (en) Chemical compounds
AU2003260436A1 (en) Pyrimidine compounds
WO2004034985A3 (en) Chemical compounds
MXPA05009428A (es) Composiciones y metodos para prevenir y tratar enfermedades relacionadas con endotoxinas.
EP1597234A4 (en) NEW COMPOUNDS